(Q44329621)

2 December 2017

title

Systemic delivery of scAAV9 expressing SMN prolongs survival in a model of spinal muscular atrophy (English)

1 reference

2 December 2017

main subject

spinal muscular atrophy

1 reference

5

1 reference

2 December 2017

6

1 reference

2 December 2017

7

1 reference

2 December 2017

Richard J Mead

4

0 references

Ke Ning

object named as

Ke Ning

series ordinal

2

0 references

author name string

Chiara F Valori

series ordinal

1

1 reference

2 December 2017

Matthew Wyles

series ordinal

3

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 June 2010

1 reference

Science Translational Medicine

2 December 2017

published in

1 reference

2 December 2017

volume

2

1 reference

2 December 2017

issue

35

1 reference

2 December 2017

page(s)

35ra42

1 reference

2 December 2017

cites work

Spinal muscular atrophy.

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000830

Identification and characterization of a spinal muscular atrophy-determining gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000830

Disruption of an SF2/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000830

Inactivation of the survival motor neuron gene, a candidate gene for human spinal muscular atrophy, leads to massive cell death in early mouse embryos

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000830

Oligonucleotide-mediated survival of motor neuron protein expression in CNS improves phenotype in a mouse model of spinal muscular atrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000830

Delivery of a read-through inducing compound, TC007, lessens the severity of a spinal muscular atrophy animal model

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000830

Effects of 2,4-diaminoquinazoline derivatives on SMN expression and phenotype in a mouse model for spinal muscular atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000830

Novel aminoglycosides increase SMN levels in spinal muscular atrophy fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000830

Neuronal SMN expression corrects spinal muscular atrophy in severe SMA mice while muscle-specific SMN expression has no phenotypic effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000830

Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000830

Intravenous administration of self-complementary AAV9 enables transgene delivery to adult motor neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000830

Rapid and highly efficient transduction by double-stranded adeno-associated virus vectors in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000830

Adeno-associated virus terminal repeat (TR) mutant generates self-complementary vectors to overcome the rate-limiting step to transduction in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000830

Gene therapy progress and prospects: recent progress in transgene and RNAi expression cassettes

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000830

The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn(-/-) mice and results in a mouse with spinal muscular atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000830

Codon bias and heterologous protein expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000830

The survival motor neuron protein in spinal muscular atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000830

Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000830

Identification of a battery of tests for drug candidate evaluation in the SMNDelta7 neonate model of spinal muscular atrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000830

Abnormal motor phenotype in the SMNDelta7 mouse model of spinal muscular atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000830

A mouse model for spinal muscular atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000830

Sustained improvement of spinal muscular atrophy mice treated with trichostatin A plus nutrition

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000830

Vascular perfusion abnormalities in infants with spinal muscular atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000830

Stimulating full-length SMN2 expression by delivering bifunctional RNAs via a viral vector.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000830

Self-inactivating lentiviral vectors with enhanced transgene expression as potential gene transfer system in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000830

RETRACTED ARTICLE: Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000830

10.1126/SCITRANSLMED.3000830

21 January 2018

Identifiers

DOI

1 reference

2 December 2017

1 reference